English
|
中文
HOME
NEWS
EVENTS
Conference
Exhibition
Laws & Regulations
About Us
CAIVD & PCEM
CAIVD
PCEM
VIEW
About VIEW
Editorial Board
Contact
Search
News
Home
>
News
New Blood Test Can Predict Future Breast Cancer
2015-07-14
The analysis of a blood sample could predict if a woman will get breast cancer within two to five years which could create a paradigm shift in early diagnosis of this malignant neoplasm as well as other diseases. ..
Blood Test Influences Clinical Decisions in Coronary Artery Disease
2015-07-07
Clinicians need better approaches to evaluating women at midlife and beyond who present to primary care with chest pain and related symptoms such as an individual's current likelihood of having obstructive coronar..
Leukemia Fusion Genes Screening Kit Gets CE IVD Status
2015-06-19
The Leukemia Fusion Genes screening kit has been released as a Conformité Européenne In Vitro Diagnostic (CE-IVD) product under the European Directive for In Vitro Diagnostic Medical Devices. The scr..
Scientists find CJD resistance gene
2015-06-12
Researchers have identified a gene that might make people resistant to the brain eating disease CJD. The study is part of an effort to find ways of combating a possible epidemic caused by eating BSE infected beef ..
Juvenile camels 'key source' of Mers
2015-06-12
Camels aged less than four years might be a major source of Mers, according to new research. An international team looked for evidence of current or past infection in more than 800 dromedary camels. They found..
New Technology Turns Smartphone into a DNA-Scanning Microscope
2015-05-22
Researchers at University of California, Los Angeles (UCLA) have developed a new technology that turns a smartphone into a DNA-scanning fluorescent microscope. Lead researcher Aydogan Ozcan, Howard Hughes Medical..
Molecular Urine Test Identifies Lung Carcinoma Mutations
2015-05-21
The monitoring of circulating tumor DNA (ctDNA) is a promising technique that may provide clinicians with a faster, cheaper and less invasive way to evaluate the clinical status and response to therapy of cancer patie..
Breath-Test Helps Diagnosis of Delayed Gastric Emptying
2015-05-08
The Gastric Emptying Breath Test (GEBT) is a new noninvasive test to aid in the diagnosis of delayed gastric emptying, known as gastroparesis and has been officially approved. Current tests used to diagnose gastro..
2014 China IVD Industry Annual Report
2015-04-24
In recent years, growing together with global IVD industry, China IVD industry is increasing at a speed of around 20% every year. According to Evaluat emedtech’s report, at the end of 2018, global IVD market wil..
Top wireless device developments of 2015? Apple's at the top, of course
2015-04-23
It may not have made much of an impression with providers when it was unveiled, but the Apple Watch is gaining ground fast, with a new provider-facing app seemingly introduced every day. Now the trendy smartwatch, w..
Swiss scientists find new way to detect lung cancer
2015-04-22
The results have important implications for the use of cancer therapies that target specific cancer mutations, explains Dr Martin Reck from the Department of Thoracic Oncology at Lung Clinic Grosshansdorf, Germany, wh..
FDA approves first-of-its-kind corneal implant to improve near vision in certain patients
2015-04-21
The U.S. Food and Drug Administration today approved the KAMRA inlay, a device implanted in the cornea of one eye (the clear, front surface) to improve near vision in certain patients with presbyopia. It is the first ..
Amgen’s new drug for heart disease is approved by FDA
2015-04-17
Amgen has won an FDA approval for the heart drug ivabradine, which will hit the market as Corlanor. This is the first approval for a new class of drug aimed at preventing hospitalization for a deteriorating heart, slo..
New research identifies potential new targets for the treatment of cancer
2015-04-13
New research at the University of Aberdeen has identified potential new targets for the treatment of certain types of cancer. This research could lead to the development of new drug therapies tailored to individua..
AstraZeneca plc (ADR) And Myriad Genetics, Inc. Expand Collaboration On Lynparza
2015-04-10
Myriad’s BRAC Analysis CDx test will be used to identify prospective patients of metastatic pancreatic cancer who could respond to AstraZeneca’s Lynparza AstraZeneca plc (ADR) (NYSE:AZN) and Myriad Gen..
Total:
3127
Pages:
209
First
Prev
1
..
202
203
204
205
206
207
208
Next
End